https://charts.traderzeitung.de/phases/US0223071020
string(1431) "{"isin":"US0223071020","name":"Alumis Inc","stock_id_xnas":51926278,"stock_id_xnys":null,"generated_at":"2026-07-10 20:29:00","days":[{"date":"2026-07-08","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":29.12,"close_at":"2026-07-08 15:27:00","complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":29.745,"close_at":"2026-07-08 21:59:00","complete":true,"perf_pct":2.1463},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":29.71,"close_at":"2026-07-08 23:53:00","complete":true,"perf_pct":-0.1177}]},{"date":"2026-07-09","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":30.29,"close_at":"2026-07-09 21:59:00","complete":true,"perf_pct":1.9522},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-07-10","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":28.42,"close_at":"2026-07-10 20:25:00","complete":false,"perf_pct":-6.1737},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"
Alumis Aktie News & Nachrichten
Trading-Room

Alumis Aktie News & Nachrichten

[WKN: A40GLK | Symbol: ALMS]
Realtimekurs
   
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel
Alumis Chart

Artikel aus der Redaktion der Trader-Zeitung

Alumis

TOP-5-Kursziele der Analysten am 11.03.26

Alumis Inc. [US0223071020] Raymond James startet Berichterstattung mit "Strong Buy" und Kursziel 46...

TOP-5-Kursziele der Analysten am 25.02.26

Alumis Inc [US0223071020] Stifel startet Berichterstattung mit "Buy" und Kursziel 44 USD (57 % Kurspotenzial)...

Phase-3-Triumph und Millionen-Spritze: Wie Alumis Inc. jetzt zum Gamechanger im Milliardenmarkt für Psoriasis avanciert

Präzisionsmedizin und innovative Immuntherapien als Kernkompetenz Alumis Inc. (ALMS) positioniert...

  • ‹
  • 1
  • ›
Alumis Nachrichtenticker öffnen
Trader-Zeitung Agentic 10.07.2026 14:20 Uhr

Alumis Inc. vor wichtigem Meilenstein: Stifel-Analyst bekräftigt Kaufempfehlung mit hohem Kursziel

Die Aktie des US-Biotech-Unternehmens Alumis Inc. rückt zunehmend in den Fokus der Wall Street. Am 9. Juli 2026 hat der renommierte Analyst Alex Thomp